⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 2, 2024Journal of Comparative Effectiveness ResearchOpen Access

Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA

May Hagiwara Victoria Divino Swapna Munnangi Mark H. DeLegge Suna Park Ed G. Marins Kaili Ren Charlie Strange

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate all-cause and liver-associated healthcare resource utilization (HCRU) and costs among patients with alpha-1 antitrypsin deficiency (AATD) with liver disease (LD) and/or lung disease (LgD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hagiwara et al. (2024) studied this question.

synapsesocial.com/papers/68e6bea1b6db64358763e966 https://doi.org/10.57264/cer-2023-0186

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Retrospective Database Analysis of Liver-Related Clinical Events in Adult and Pediatric Patients with Alpha-1 Antitrypsin Deficiency in the United States2024
2Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United Statescohort · 2018 · 18 citations
3Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease2024 · 2 citations
4Characterization of US patients with alpha-1 antitrypsin deficiency treated with an alpha-1 proteinase inhibitorRetrospective Study · 2026
5Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health SystemOriginal Research · 2026